TNF and COVID-19: Supplementary Table S1 lists the 10 most frequently cited publications. “Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry (31)” by Ungaro RC et al. had the highest number of total citations.